The NF1 tumor suppressor gene encodes a GTPase-activating protein called neurofibromin that negatively regulates Ras signaling. Mutations in NF1 cause neurofibromatosis type 1 (NF1). The development of neurofibromas, which are complex tumors composed of multiple cell types, is a hallmark of NF1. Somatic inactivation of murine Nf1 in Schwann cells is necessary, but not sufficient, to initiate neurofibroma formation. Neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/–) microenvironment. Mast cells infiltrate neurofibromas, where they secrete proteins that can remodel the ECM and initiate angiogenesis. Thus, identification of mechanisms responsible for mast cell migration to tumor microenvironments is important for understanding tumorigenesis and for designing potential therapies. Here, we show that homozygous Nf1 mutant (Nf1–/–) Schwann cells secrete Kit ligand (KitL), which stimulates mast cell migration, and that Nf1+/– mast cells are hypermotile in response to KitL. Furthermore, we link hyperactivation of the Ras-class IA-PI3K-Rac2 pathway to increased Nf1+/– mast cell migration. Thus, these studies identify a novel interaction between Nf1–/– Schwann cells and Nf1+/– mast cells that is likely to be important in neurofibroma formation.
Yang Feng-Chun, David A. Ingram, Shi Chen, Cynthia M. Hingtgen, Nancy Ratner, Kelly R. Monk, Travis Clegg, Hilary White, Laura Mead, Mary Jo Wenning, David A. Williams, Reuben Kapur, Simon J. Atkinson, D. Wade Clapp
Title and authors | Publication | Year |
---|---|---|
Dysregulated mast cell activation induced by diabetic milieu exacerbates the progression of diabetic peripheral neuropathy in mice
Yao X, Wang X, Zhang R, Kong L, Fan C, Qian Y |
Nature Communications | 2025 |
Treatment of Plexiform Neurofibromas : Current Perspectives on Surgery and Medical Treatment.
Hwang JK, Kim SH, Kim DS |
Journal of Korean Neurosurgical Society | 2025 |
Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas
Helena Mazuelas, Míriam Magallón-Lorenz, Itziar Uriarte-Arrázola, Alejandro Negro, Inma Rosas, Ignacio Blanco, Elisabeth Castellanos, Conxi Lázaro, Bernat Gel, Meritxell Carrió, Eduard Serra |
JCI Insight | 2024 |
SOX9 Promotes Collagen VI Secretion by Upregulating PCOLCE in Neurofibroma.
Yao X, Wang B, Su Y, Bing Z, Li Q, Dong Q, Yin H, Wang J, Pan Y, Yuan G |
Molecular Neurobiology | 2024 |
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis
Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N |
Life science alliance | 2024 |
The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation
White EE, Rhodes SD |
Cancers | 2024 |
Interactions between Schwann cell and extracellular matrix in peripheral nerve regeneration.
Jiang M, Chen M, Liu N |
Frontiers in neurology | 2024 |
NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14.
Patritti-Cram J, Rahrmann EP, Rizvi TA, Scheffer KC, Phoenix TN, Largaespada DA, Ratner N |
iScience | 2024 |
Unlocking the regenerative key: Targeting stem cell factors for bone renewal
Karima G, Kim HD |
Journal of Tissue Engineering | 2024 |
Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas
Armstrong AE, Belzberg AJ, Crawford JR, Hirbe AC, Wang ZJ |
BMC Cancer | 2023 |
Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model
McLean DT, Meudt JJ, Lopez Rivera LD, Schomberg DT, Pavelec DM, Duellman TT, Buehler DG, Schwartz PB, Graham M, Lee LM, Graff KD, Reichert JL, Bon-Durant SS, Konsitzke CM, Ronnekleiv-Kelly SM, Shanmuganayagam D, Rubinstein CD |
Frontiers in Oncology | 2023 |
Econazole selectively induces cell death in NF1-homozygous mutant tumor cells
Lakes YB, Moye SL, Mo J, Tegtmeyer M, Nehme R, Charlton M, Salinas G, McKay RM, Eggan K, Le LQ |
Cell reports. Medicine | 2023 |
Neurofibromin and suppression of tumorigenesis: beyond the GAP
J Mo, S Moye, R McKay, L Le |
Oncogene | 2022 |
Current concepts of neurofibromatosis type 1: pathophysiology and treatment.
Choi J, An S, Lim SY |
Archives of Craniofacial Surgery | 2022 |
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
Leah J Kershner, Kwangmin Choi, Jianqiang Wu, Xiyuan Zhang, Melissa Perrino, Nathan Salomonis, Jack Shern, Nancy Ratner |
JCI Insight | 2022 |
Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development
T Mohamad, C Plante, JP Brosseau |
International journal of molecular sciences | 2021 |
Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression
D Sun, XP Xie, X Zhang, Z Wang, SF Sait, SV Iyer, YJ Chen, R Brown, DR Laks, ME Chipman, JF Shern, LF Parada |
Cell Stem Cell | 2021 |
Insights into the Pathogenesis of NF1-Associated Neoplasms
A Bui, C Jiang, RM McKay, LJ Klesse, LQ Le |
2021 | |
Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing
JP Brosseau, AA Sathe, Y Wang, T Nguyen, DA Glass, C Xing, LQ Le |
Acta Neuropathologica Communications | 2021 |
Tumorigenesis in neurofibromatosis type 1: role of the microenvironment
C Jiang, RM McKay, LQ Le |
Oncogene | 2021 |
WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth
CS Thomson, J Pundavela, MR Perrino, RA Coover, K Choi, KE Chaney, TA Rizvi, DA Largaespada, N Ratner |
Oncogene | 2021 |
The roles of GTPase-activating proteins in regulated cell death and tumor immunity
H He, J Huang, S Wu, S Jiang, L Liang, Y Liu, W Liu, L Xie, Y Tao, Y Jiang, L Cong |
Journal of Hematology & Oncology | 2021 |
Cutaneous Findings in Neurofibromatosis Type 1
Ozarslan B, Russo T, Argenziano G, Santoro C, Piccolo V |
Cancers | 2021 |
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis in a Pediatric Patient With Neurofibromatosis Type 1
Lehan E, Wang T, Soboleski D, Acker A, Kehar M |
ACG Case Reports Journal | 2021 |
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
AE Armstrong, SD Rhodes, A Smith, S Chen, W Bessler, MJ Ferguson, L Jiang, X Li, J Yuan, X Yang, FC Yang, KA Robertson, DA Ingram, JO Blakeley, DW Clapp |
Pediatric Blood & Cancer | 2020 |
Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer
HN Vasudevan, CH Lucas, JE Villanueva-Meyer, PV Theodosopoulos, DR Raleigh |
Neurosurgery | 2020 |
Neuronal lineages derived from the nerve-associated Schwann cell precursors
P Kameneva, ME Kastriti, I Adameyko |
Cellular and Molecular Life Sciences | 2020 |
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST
KE Chaney, MR Perrino, LJ Kershner, AV Patel, J Wu, K Choi, TA Rizvi, E Dombi, S Szabo, DA Largaespada, N Ratner |
Cancer research | 2020 |
A narrative review of the role of fibroblasts in the growth and development of neurogenic tumors
Wei CJ, Gu YH, Wang W, Ren JY, Cui XW, Lian X, Liu J, Wang HJ, Gu B, Li QF, Wang ZC |
Annals of translational medicine | 2020 |
Cxcr3 expressing leukocytes are necessary for neurofibroma formation in mice
Jonathan Fletcher, Jianqiang Wu, Walter J Jessen, Jay Pundavela, Jacob A. Miller, Eva Dombi, Mi-Ok Kim, Tilat Rizvi, Kashish Chetal, Nathan Salomonis, Nancy Ratner |
JCI Insight | 2019 |
Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1
RA de Vasconcelos, PG Coscarelli, TM Vieira, WS Noguera, DC Rapozo, MA Acioly |
Cancer Medicine | 2019 |
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin
FL Rice, G Houk, JP Wymer, SJ Gosline, J Guinney, J Wu, N Ratner, MP Jankowski, SL Rosa, M Dockum, JR Storey, SL Carroll, PJ Albrecht, VM Riccardi, C Sommer |
PloS one | 2019 |
Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside
J Korfhage, DB Lombard |
Molecular cancer research : MCR | 2019 |
After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation
JS Fletcher, J Pundavela, N Ratner |
2019 | |
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis
CJ Wei, SC Gu, JY Ren, YH Gu, XW Xu, X Chou, X Lian, X Huang, HZ Li, YS Gao, B Gu, T Zan, ZC Wang, QF Li |
2019 | |
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1 -Deficient Mice
CA Burks, SD Rhodes, WK Bessler, S Chen, A Smith, JR Gehlhausen, ET Hawley, L Jiang, X Li, J Yuan, Q Lu, M Jacobsen, GE Sandusky, DR Jones, DW Clapp, JO Blakeley |
Molecular cancer therapeutics | 2019 |
Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis
Chung-Ping Liao, Reid Booker, Jean-Philippe Brosseau, Zhiguo Chen, Juan Mo, Edem Tchegnon, Yong Wang, D. Wade Clapp, Lu Le |
Journal of Clinical Investigation | 2018 |
Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms:
JF Longo, SM Weber, BP Turner-Ivey, SL Carroll |
Advances in Anatomic Pathology | 2018 |
Cutaneous neurofibromas in the genomics era: current understanding and open questions
RJ Allaway, SJ Gosline, SL Rosa, P Knight, A Bakker, J Guinney, LQ Le |
British Journal of Cancer | 2018 |
NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
JP Brosseau, CP Liao, Y Wang, V Ramani, T Vandergriff, M Lee, A Patel, K Ariizumi, LQ Le |
Nature Communications | 2018 |
The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities.
Brosseau JP, Pichard DC, Legius EH, Wolkenstein P, Lavker RM, Blakeley JO, Riccardi VM, Verma SK, Brownell I, Le LQ |
Neurology | 2018 |
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
V Staedtke, RY Bai, JO Blakeley |
Neurotherapeutics | 2017 |
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors
S Karmakar, KM Reilly |
CNS Oncology | 2017 |
An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system
K Choi, K Komurov, JS Fletcher, E Jousma, JA Cancelas, J Wu, N Ratner |
Scientific Reports | 2017 |
Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma: BARGAGNA-MOHAN, et al
P Bargagna-Mohan, A Ishii, L Lei, D Sheehy, S Pandit, G Chan, R Bansal, R Mohan |
Journal of Neuroscience Research | 2017 |
The role of stem cells in benign tumors
H Qin, D Bao, X Tong, Q Hu, G Sun, X Huang |
Tumor Biology | 2016 |
Contextual signaling in cancer
LJ Smithson, C Anastasaki, R Chen, JA Toonen, SB Williams, DH Gutmann |
Seminars in Cell & Developmental Biology | 2016 |
The Challenge of Cancer Genomics in Rare Nervous System Neoplasms
SL Carroll |
The American Journal of Pathology | 2016 |
Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice
L He, Z Zhu, S Chen, Y Wang, H Gu |
Cancer Medicine | 2016 |
Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma IM, Clapp DW, Gutmann DH |
Oncotarget | 2016 |
The New Deal: A Potential Role for Secreted Vesicles in Innate Immunity and Tumor Progression
A Benito-Martin, AD Giannatale, S Ceder, HÃ Peinado |
Frontiers in immunology | 2015 |
Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells
Y Zhou, Y He, R Sharma, W Xing, S Estwick, X Wu, S Rhodes, M Xu, FC Yang |
International journal of molecular sciences | 2015 |
Preclinical evidence for the use of sunitinib malate in the treatment of plexiform neurofibromas: Sunitinib Malate in Plexiform Neurofibroma Therapy
MJ Ferguson, SD Rhodes, L Jiang, X Li, J Yuan, X Yang, S Zhang, ST Vakili, P Territo, G Hutchins, FC Yang, DA Ingram, DW Clapp, S Chen |
Pediatric Blood & Cancer | 2015 |
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
C Stockmann, D Schadendorf, R Klose, I Helfrich |
Frontiers in Oncology | 2014 |
Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice
Yan Li, Wen Xing, Yong-Zheng He, Shi Chen, Steven D. Rhodes, Jin Yuan, Yuan Zhou, Jun Shi, Jie Bai, Feng-Kui Zhang, Wei-Ping Yuan, Tao Cheng, Ming-Jiang Xu, Feng-Chun Yang |
Stem Cell Investigation | 2014 |
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice
R Sharma, X Wu, SD Rhodes, S Chen, Y He, J Yuan, J Li, X Yang, X Li, L Jiang, ET Kim, DA Stevenson, D Viskochil, M Xu, FC Yang |
Human Molecular Genetics | 2013 |
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis
SN Brosius, AN Turk, SJ Byer, NM Brossier, L Kohli, A Whitmire, FM Mikhail, KA Roth, SL Carroll |
Acta Neuropathologica | 2013 |
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
SJ Park, B Sawitzki, L Kluwe, VF Mautner, N Holtkamp, A Kurtz |
BMC Medicine | 2013 |
FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
S Licciulli, J Maksimoska, C Zhou, S Troutman, S Kota, Q Liu, S Duron, D Campbell, J Chernoff, J Field, R Marmorstein, JL Kissil |
2013 | |
Skin-Derived Precursor Cells as an In Vitro Modelling Tool for the Study of Type 1 Neurofibromatosis
A Gutiérrez-Rivera, H Iribar, A Tuneu, A Izeta |
Stem Cells International | 2012 |
Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extension
K Dahlgaard, A Jung, K Qvortrup, H Clausen, O Kjaerulff, HH Wandall |
Proceedings of the National Academy of Sciences | 2012 |
The Plexiform Neurofibroma Microenvironment
FC Yang, K Staser, DW Clapp |
Cancer Microenvironment | 2012 |
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
CE Prada, E Jousma, TA Rizvi, J Wu, RS Dunn, DA Mayes, JA Cancelas, E Dombi, MO Kim, BL West, G Bollag, N Ratner |
Acta Neuropathologica | 2012 |
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
KA Robertson, G Nalepa, FC Yang, DC Bowers, CY Ho, GD Hutchins, JM Croop, TA Vik, SC Denne, LF Parada, CM Hingtgen, LE Walsh, M Yu, KR Pradhan, MK Edwards-Brown, MD Cohen, JW Fletcher, JB Travers, KW Staser, MW Lee, MR Sherman, CJ Davis, LC Miller, DA Ingram, DW Clapp |
The Lancet Oncology | 2012 |
The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1
X Wu, S Chen, Y He, SD Rhodes, KS Mohammad, X Li, X Yang, L Jiang, G Nalepa, P Snider, AG Robling, DW Clapp, SJ Conway, TA Guise, FC Yang |
PloS one | 2011 |
Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system
NM Brossier, SL Carroll |
Brain Research Bulletin | 2011 |
Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms
SL Carroll |
Acta Neuropathologica | 2011 |
Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model
W Zhang, SD Rhodes, L Zhao, Y He, Y Zhang, Y Shen, D Yang, X Wu, X Li, X Yang, SJ Park, S Chen, C Turner, FC Yang |
Bone | 2011 |
Neurofibromatosis-1 Heterozygosity Increases Microglia in a Spatially- and Temporally-Restricted Pattern Relevant to Mouse Optic Glioma Formation and Growth
GW Simmons, WW Pong, RJ Emnett, CR White, SM Gianino, FJ Rodriguez, DH Gutmann |
Journal of Neuropathology and Experimental Neurology | 2011 |
Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation
M Olaopa, H Zhou, P Snider, J Wang, RJ Schwartz, AM Moon, SJ Conway |
Developmental Biology | 2011 |
Multiple Increased Osteoclast Functions in Individuals with Neurofibromatosis Type 1
DA Stevenson, J Yan, Y He, H Li, Y Liu, Q Zhang, Y Jing, Z Guo, W Zhang, D Yang, X Wu, H Hanson, X Li, K Staser, DH Viskochil, JC Carey, S Chen, L Miller, K Roberson, L Moyer-Mileur, M Yu, EL Schwarz, M Pasquali, FC Yang |
American journal of medical genetics. Part A | 2011 |
The Pathoetiology of Neurofibromatosis 1
EM Jouhilahti, S Peltonen, AM Heape, J Peltonen |
The American Journal of Pathology | 2011 |
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression
K Staser, FC Yang, DW Clapp |
Annual review of pathology | 2011 |
Kinase suppressor of Ras (KSR1) modulates multiple kit-ligand-dependent mast cell functions
M Chen, S Burgin, K Staser, Y He, X Li, M Robinson, L Jiang, RJ Chan, D Ingram, DW Clapp |
Experimental Hematology | 2011 |
Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells
K Staser, FC Yang, DW Clapp |
Current Opinion in Hematology | 2010 |
Mast cells and the neurofibroma microenvironment
K Staser, FC Yang, DW Clapp |
Blood | 2010 |
Nf1−/− Schwann Cell-Conditioned Medium Modulates Mast Cell Degranulation by c-Kit-Mediated Hyperactivation of Phosphatidylinositol 3-Kinase
S Chen, S Burgin, A McDaniel, X Li, J Yuan, M Chen, W Khalaf, DW Clapp, FC Yang |
The American Journal of Pathology | 2010 |
Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer
C Yi, J Maksimoska, R Marmorstein, JL Kissil |
Biochemical Pharmacology | 2010 |
Glial Cell Lines: An Overview
De Vries GH, Boullerne AI |
Neurochemical Research | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Mice lacking neurofibromin develop gastric hyperplasia
L Lin, J Chen, JA Richardson, LF Parada |
American journal of physiology. Gastrointestinal and liver physiology | 2009 |
Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase
F Kweh, M Zheng, E Kurenova, M Wallace, V Golubovskaya, WG Cance |
Molecular Carcinogenesis | 2009 |
Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas
LQ Le, T Shipman, DK Burns, LF Parada |
Cell Stem Cell | 2009 |
Mast cells can contribute to axon-glial dissociation and fibrosis in peripheral nerve
KR Monk, J Wu, JP Williams, BA Finney, ME Fitzgerald, MD Filippi, N Ratner |
Neuron Glia Biology | 2008 |
How does the Schwann cell lineage form tumors in NF1?
SL Carroll, N Ratner |
Glia | 2008 |
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells
AS McDaniel, JD Allen, SJ Park, ZM Jaffer, EG Michels, SJ Burgin, S Chen, WK Bessler, C Hofmann, DA Ingram, J Chernoff, DW Clapp |
Blood | 2008 |
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
FC Yang, DA Ingram, S Chen, Y Zhu, J Yuan, X Li, X Yang, S Knowles, W Horn, Y Li, S Zhang, Y Yang, ST Vakili, M Yu, D Burns, K Robertson, G Hutchins, LF Parada, DW Clapp |
Cell | 2008 |
It takes a (dysfunctional) village to raise a tumor
KM Reilly, TV Dyke |
Cell | 2008 |
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells
J Wu, JP Williams, TA Rizvi, JJ Kordich, D Witte, D Meijer, AO Stemmer-Rachamimov, JA Cancelas, N Ratner |
Cancer Cell | 2008 |
Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life
SJ Morrison, AC Spradling |
Cell | 2008 |
Suppression of Proliferation of Two Independent NF1 Malignant Peripheral Nerve Sheath Tumor Cell Lines by the pan-ErbB Inhibitor CI-1033
Dilworth JT, Wojtkowiak JW, Mathieu P, Tainsky MA, Reiners JJ Jr, Mattingly RR, Hancock CN |
Cancer biology & therapy | 2008 |
Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.
Bartelt-Kirbach B, Wuepping M, Dodrimont-Lattke M, Kaufmann D |
neurogenetics | 2008 |
Angiogenic Expression Profile of Normal and Neurofibromin-Deficient Human Schwann Cells
SL Thomas, GH Vries |
Neurochemical Research | 2007 |
Phosphatidylinositol 3-Kinase and Akt Nonautonomously Promote Perineurial Glial Growth in Drosophila Peripheral Nerves
W Lavery, V Hall, JC Yager, A Rottgers, MC Wells, M Stern |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2007 |
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs
LQ Le, LF Parada |
Oncogene | 2007 |
Molecular Dissection of Isolated Disease Features in Mosaic Neurofibromatosis Type 1
Maertens O, De Schepper S, Vandesompele J, Brems H, Heyns I, Janssens S, Speleman F, Legius E, Messiaen L |
The American Journal of Human Genetics | 2007 |
Deletion of Nf1 in Neurons Induces Increased Axon Collateral Branching after Dorsal Root Injury
Romero MI, Lin L, Lush ME, Lei L, Parada LF, Zhu Y |
Journal of Neuroscience | 2007 |
Hyperactivation of p21ras and PI3-K cooperate to alter murine and human NF1 haploinsufficient osteoclast functions
Feng-Chun Yang; Shi Chen; Alexander Robling; Xijie Yu; Todd D. Nebesio; Trent Morgan; Xiaohong Li; Jin Yuan; Janet Hock; David A. Ingram; D. Wade Clapp |
Journal of Clinical Investigation | 2006 |
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling
FC Yang, S Chen, T Clegg, X Li, T Morgan, SA Estwick, J Yuan, W Khalaf, S Burgin, J Travers, LF Parada, DA Ingram, DW Clapp |
Human Molecular Genetics | 2006 |
Genetic reduction of class IA PI-3 kinase activity alters fetal hematopoiesis and competitive repopulating ability of hematopoietic stem cells in vivo
LS Haneline, H White, FC Yang, S Chen, C Orschell, R Kapur, DA Ingram |
Blood | 2006 |
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis
BC Ling, J Wu, SJ Miller, KR Monk, R Shamekh, TA Rizvi, G Decourten-Myers, KS Vogel, JE DeClue, N Ratner |
Cancer Cell | 2005 |
Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.
Hiatt K, Ingram DA, Huddleston H, Spandau DF, Kapur R, Clapp DW |
The American Journal of Pathology | 2004 |
It takes two to tango: mast cell and Schwann cell interactions in neurofibromas
DH Viskochil |
Journal of Clinical Investigation | 2003 |